Revag Biosciences Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24239TG2004PLC043602 Incorporated 07 July 2004 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Public Limited Company healthcare
Data last updated
Revenue · FY 2025
₹1.41 Lakh
Latest filing
Net loss · FY 2025
₹1.24 Lakh
Net margin -87.8%
EBITDA · FY 2025
₹83,633
EBITDA margin 59.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹5.5 Lakh
Satisfied ₹1.7 Cr
Company age
22 yrs
Est. 2004
Directors on board
3
As per MCA filings

About Revag Biosciences Limited

Data last updated:

Revag Biosciences Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 07 July 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PLC043602. Its GSTIN is 36AADCR2369D1ZH (Telangana).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Laxminarayana Rau Praharaju and Rajyalakshmi Praharaju.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.41 Lakh. For the same year it recorded a net loss of ₹1.24 Lakh (net margin -87.8%) and EBITDA of ₹83,633 (EBITDA margin 59.3%). Revenue has declined at a compounded annual rate (CAGR) of 49% over five years.

As per MCA filings, the company has open charges of ₹5.5 Lakh and satisfied charges of ₹1.7 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24239TG2004PLC043602
Registration Number 043602
Incorporation Date 07 July 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Revag Biosciences has one previous CIN (Corporate Identification Number): U24239AP2004PLC043602. The current CIN is U24239TG2004PLC043602, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239TG2004PLC043602Current
U24239AP2004PLC043602Previous

Contact details

Revag Biosciences Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Revag Biosciences Limited, buy the company report.

Comprehensive company report
Revag Biosciences Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Revag Biosciences Limited

FY 2025 filings available

Revag Biosciences Limited reported revenue of ₹1.41 Lakh for FY 2025.

Revenue · FY 2025
₹1.41 Lakh
Net loss · FY 2025
₹1.24 Lakh margin -87.8%
EBITDA · FY 2025
₹83,633 margin 59.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
5 years · compounded
▼ 49%
EBITDA CAGR growth
1 year
▲ 246%
3 years · compounded
▲ 29%
5 years · compounded
▼ 25%

Revenue has declined at a compounded annual rate (CAGR) of 49% over five years. EBITDA rose 246% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹83,633
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.24 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin59.3%
Net Profit Margin-87.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Revag Biosciences Limited, buy the company report.

Board of directors of Revag Biosciences Limited

Revag Biosciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Laxminarayana Rau PraharajuDirector07 Jul 200422 Years 3 MonthsCurrent
Rajyalakshmi PraharajuDirector21 Mar 20188 Years 7 MonthsCurrent
Anurag Athreya PraharajuDirector21 Mar 20188 Years 7 MonthsCurrent

Peer comparison

Revag Biosciences Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Biosciences, Preventive Healthcare Services), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Aviom Medcare at Home Private Limited₹1.43 Lakh (FY 2025)-86.0%New Delhi, Delhi, India
Blissful Health Services Private Limited₹1.42 Lakh (FY 2024)2.0%New Delhi, Delhi, India
Revag Biosciences Limitedthis company₹1.41 Lakh (FY 2025)-₹1.24 Lakh-87.8%Hyderabad, Telangana, India
Yashoda Healthcare Private Limited₹1.39 Lakh (FY 2024)8.0%New Delhi, Delhi, India
Primecare Global Private Limited₹1.37 Lakh (FY 2025)5.0%Bangalore, Karnataka, India

To see the full peer comparison of Revag Biosciences Limited, buy the company report.

Auditor

Revag Biosciences Limited is audited by P MURALI & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
P MURALI & COFY 2023007257S

Shareholding

The shareholding of Revag Biosciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Revag Biosciences Limited, buy the company report.

Charges & borrowings

Open charges
₹5.5 Lakh
Satisfied charges
₹1.7 Cr
Breakdown by lending institutions
State Bank of India₹1.65 Cr
State Bank of Hyderabad₹0.06 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Sep 2020100386942State Bank of India₹1.65 CrSatisfied
20 Mar 201510567567State Bank of Hyderabad₹5.5 LakhSatisfied

To see the full charge records of Revag Biosciences Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Revag Biosciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Revag Biosciences has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AADCR2369D1ZHTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Revag Biosciences Limited, buy the company report.

Recent activity

Revag Biosciences Limited has 7 board changes on record since 2004: 3 appointments and 4 cessations. The latest: Anurag Athreya Praharaju ceased to be Additional Director on 29 Sep 2018.

AGM
Revag Biosciences Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 20 Mar 2015 via Charge ID 10567567 with State Bank Of Hyderabad was fully satisfied on 28 Jul 2025.
Charges
A charge registered on 01 Sep 2020 via Charge ID 100386942 with State Bank Of India was fully satisfied on 25 Jun 2025.
Filing
Revag Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India amounted to Rs. 164.86 Lakh with Charge ID 100386942 was registered on 01 Sep 2020.
Ceased
Anurag Athreya Praharaju ceased to be Additional Director.
Ceased
Rajyalakshmi Praharaju ceased to be Additional Director.
Ceased
Ratna Rao Vissa ceased to be Whole-Time Director.
Ceased
Venkatasubbarao Potluri ceased to be Director.
Appointed
Anurag Athreya Praharaju was appointed as Director.
Appointed
Rajyalakshmi Praharaju was appointed as Director.
Charges
A charge with State Bank Of Hyderabad amounted to Rs. 5.50 Lakh with Charge ID 10567567 was registered on 20 Mar 2015.

2 earlier events are in the company report.

Frequently asked questions

Revag Biosciences is an active public limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 07 July 2004 (22+ years old) and is registered under CIN U24239TG2004PLC043602.

Revag Biosciences has 3 current directors:

The latest financial statements of Revag Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Revag Biosciences is 36AADCR2369D1ZH, registered in Telangana.

The CIN (Corporate Identification Number) of Revag Biosciences is U24239TG2004PLC043602. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Revag Biosciences was incorporated on 07 July 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Revag Biosciences by revenue are Aviom Medcare at Home Private Limited, Blissful Health Services Private Limited, Yashoda Healthcare Private Limited, Primecare Global Private Limited, all in the Healthcare industry (Biosciences, Preventive Healthcare Services), with the same principal business activity (medical and dental practice, nursing, pathology, blood bank services, etc.).

Anurag Athreya Praharaju ceased to be Additional Director on 29 Sep 2018. Rajyalakshmi Praharaju ceased to be Additional Director on 29 Sep 2018. Ratna Rao Vissa ceased to be Whole-Time Director on 26 Mar 2018. Revag Biosciences has 7 board changes on record in total.

The registered office of Revag Biosciences is at Plot No 35E1 Phase 5 Ida Cherlapally, Hyderabad, Telangana, India – 500051.

Revag Biosciences operates in the healthcare industry, in the preventive health services segment.

Revag Biosciences has open charges of ₹5.5 Lakh and satisfied charges of ₹1.7 Cr as per latest MCA filings.